"The 'Rerate' Reality Check"3 Feb 2026 09:05
As of February 2026, Tekcapital trades at roughly 11p, representing a deep ~60% discount to its 26p NAV. Closing this gap usually happens in stages, not in a single session:
Stage 1: NAV Uplift
A successful Guident IPO at the $4–$5 range could push Tekcapital’s NAV toward 32p, as the stake is currently carried at a lower private valuation.
Stage 2: Discount Compression
Historically, UK IP commercialization peers like IP Group (~45% discount) and Frontier IP (~35%) trade at discounts of 15%–45%. If Tekcapital’s discount compresses to 30%–40% post-IPO, the share price could rise to 19p–22p.
Stage 3: Market Confidence
Fully closing the gap to 26p+ likely requires further liquidity events, such as the repayment of the $4.5m loan note or a special dividend. These will come once Guident’s IPO gives investors clarity on the asset’s market value.
Analyst & Sentiment Outlook
Current Target: Analysts have set a 15p price target, representing a 40% upside, but this doesn’t factor in Guident’s IPO uplift.
Market Pressure: Once Guident is publicly traded, the LSE will likely be forced to adjust Tekcapital's price to reflect the new, liquid value of its largest holding.
Key Risks: Historical IPOs, like MicroSalt, have sometimes led to short-term volatility, but Guident’s IPO is a much larger catalyst with a stake that could be worth more than Tek’s entire market cap.
Bottom Line: The stage is set - if Guident hits the market at the expected valuation, expect the revaluation of Tekcapital to follow.
Sign In
Follow the stocks
